Omega-3 demand brings profits for Clover

Growing demand for omega-3 fatty acids significantly boosted
profits at Australian health ingredients firm Clover Corporation
last year but lower-than-expected sales in Europe and restricted
supply of ARA oil for its fortified infant formula stopped it short
of meeting targets.

The company, which refines and sells the omega-3 fatty acid DHA in both oil form and microencapsulated powder, increased supply of the ingredient to customers by 70 per cent over the previous year, generating A$15.6 million (€9m) in revenue.

New contracts with companies such as Scotland's Natural Fruit and Beverage Company, producing a DHA-enriched juice for children, as well as interest from a number of bakeries in omega-3 fortified breads following the success of George Weston Foods' Tip Top Up range, are driving the growth in sales.

However the rapidly growing omega-3 market has also raised the number of competing products on the market and Clover says it is looking for alternative, less costly, sources of omega-3 in an attempt to reduce the the price pressure.

It has also been under pressure to supply the infant formula market, a strong source of growth in sales to Asia, because of problems in supply of the fatty acid ARA (arachiadonic acid), manufactured by DSM for US-based Martek.

ARA is a key ingredient to Omega-3 DHA enriched infant formula but production problems at DSM last year impacted global supply of this ingredient. Oil supply is not expected to return to normal untilafter September.

Clover has however made moves in the US market, appointing a US-based development manager during 2003 to capitalize on growing consumer awareness of the health benefits of omega-3 DHA.

At least six multinationals are trialling its DHA products, said the company, with results from several of these looking promising.

Other new products under development include a new soy flour, developed through a joint venture with Austgrains, and expected to be commercialized during December 2004. R&D staff are currently working in a pilot plant on applications for the ingredient in the bakery, cereal and beverage areas and a number of customers are expected to start buying the product early in 2005, according to Clover.

The company reported profits of $1.2 million for the year, up 168 per cent over last year, with sales to the end of June reaching $17 million, up 54 per cent on the prior year. Clover also made a fraction of its revenue (9 per cent) from pharmaceutical raw material distribution.

Related topics Omega-3s & nutritional oils

Related news

Related products

show more

Algal Oil or Fish Oil: Which Should I Choose?

Algal Oil or Fish Oil: Which Should I Choose?

Content provided by GC Rieber VivoMega™ | 04-Oct-2024 | Infographic

Are you fishing for answers when it comes to omega-3s from fish oil vs. algal oil? Do you find yourself asking if EPA or DHA from fish oil is the same...

Meeting Consumers’ Demand for Plant-Based Omegas

Meeting Consumers’ Demand for Plant-Based Omegas

Content provided by Fruit D'or | 17-Jul-2024 | White Paper

Omega supplement brands looking to offer alternatives to fish oil now have a solution for consumers concerned about the environment, availability, and...

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 18-Jun-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Ride the next wave of omega-3 innovation

Ride the next wave of omega-3 innovation

Content provided by dsm-firmenich | 01-Jun-2024 | Insight Guide

Fish oil supplies can’t scale to meet the needs of the planet’s growing population, but life’s®OMEGA can.

Related suppliers

Follow us

Products

View more

Webinars